| Journal of General Virology |
| First posted online 20 July 2001 | REVIEW ARTICLE |
| DOI: 10.1099/vir.0.17772-0 |
Heinz Feldmann,1 Viktor E. Volchkov,2 Valentina A. Volchkova,2 Ute Ströher3 and Hans-Dieter Klenk3
1 Canadian Science Centre for
Human and Animal Health, 1015 Arlington Street, Winnipeg, Manitoba, Canada
R3E 3R2
2 Biologie des Filovirus, Claude Bernard University Lyon-1, 46
Allée d'Italie, 69007 Lyon, France
3 Institut für Virologie, Philipps-Universität,
Robert-Koch-Str. 17, D-35037 Marburg, Germany
Marburg and Ebola viruses cause systemic
infections leading to severe haemorrhagic fever in human and non-human
primates. There is evidence that the filovirus glycoproteins play an
important role in cell tropism, the spread of infection and pathogenicity.
Biosynthesis of the transmembrane glycoprotein involves a series of co-
and post-translational events, including proteolytic cleavage by a host
cell protease. Cleavage leads to two disulphide-linked subunits, GP1 and
GP2, of which GP2
anchors the molecule into the membrane. Although cleavage
is not a requirement for Ebola virus infectivity in cell culture, the role
of cleavage in vivo is unknown. Different strains of Ebola virus
show
variations in the cleavability of the glycoprotein that may account for differences in pathogenicity. Expression of the transmembrane
glycoprotein of Ebola virus, but not of Marburg virus, requires
transcriptional editing. Unedited transcripts yield the non-structural
glycoprotein sGP, which is extensively secreted from infected cells. The
role of the different soluble glycoproteins produced during filovirus
infections is unknown, but they may interfere with the host immune
response and other defence mechanisms.
© 2001 SGM
This article is now available in the December 2001 print issue of JGV (vol. 82, 28392848). The complete issue of the journal may be seen in electronic form on JGV Online.